Vimarsana
Biggest News Aggregation in the World

Page 4 - Hookipa Pharma News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Hookipa Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Hookipa Pharma Today - Breaking & Trending Today

HOOKIPA Pharma Reports Third Quarter 2023 Financial Results and Recent Business Highlights - Vimarsana News

HOOKIPA Pharma Reports Third Quarter 2023 Financial Results and Recent Business Highlights

Reported positive preliminary Phase 2 data on additional patients for HB-200 in combination with pembrolizumab in the 1st-line setting for advanced HPV16+ head and neck cancer; data reinforce strong objective response rate and disease control rate reported in Q2 2023; randomized trial expected to start in 2024 Published peer-reviewed preclinical data, in collaboration with Gilead Sciences, for HB-400 program in The Journal of Infectious Disease Recruitment ongoing for two Phase 1 clinical trials

Source: yahoo.com
Hookipa Pharma's (HOOK) Outperform Rating Reaffirmed at Royal Bank of Canada - Vimarsana News

Hookipa Pharma's (HOOK) Outperform Rating Reaffirmed at Royal Bank of Canada

Royal Bank of Canada reiterated their outperform rating on shares of Hookipa Pharma (NASDAQ:HOOK – Free Report) in a research report released on Wednesday morning, Benzinga reports. Royal Bank of Canada currently has a $7.00 target price on the stock. Several other equities research analysts have also issued reports on HOOK. HC Wainwright lowered their […]

Source: wkrb13.com
Hookipa Pharma (NASDAQ:HOOK) Earns "Buy" Rating from Truist Financial - Vimarsana News

Hookipa Pharma (NASDAQ:HOOK) Earns "Buy" Rating from Truist Financial

Truist Financial restated their buy rating on shares of Hookipa Pharma (NASDAQ:HOOK – Free Report) in a research note published on Wednesday, Benzinga reports. They currently have a $4.00 price target on the stock. Several other brokerages have also issued reports on HOOK. Royal Bank of Canada reissued an outperform rating and issued a $7.00 […]

Some Analysts Just Cut Their HOOKIPA Pharma Inc. (NASDAQ:HOOK) Estimates - Vimarsana News

Some Analysts Just Cut Their HOOKIPA Pharma Inc. (NASDAQ:HOOK) Estimates

One thing we could say about the analysts on HOOKIPA Pharma Inc. ( NASDAQ:HOOK ) - they aren't optimistic, having just...

Source: yahoo.com
Hookipa Pharma (NASDAQ:HOOK) Announces Earnings Results - Vimarsana News

Hookipa Pharma (NASDAQ:HOOK) Announces Earnings Results

Hookipa Pharma (NASDAQ:HOOK – Get Free Report) posted its quarterly earnings results on Thursday. The company reported ($0.22) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.21) by ($0.01), reports. The company had revenue of $2.68 million during the quarter, compared to the consensus estimate of $3.54 million. Hookipa Pharma had a […]